Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of ARS 150.24 trillion. The enterprise value is 178.11 trillion.

Market Cap	150.24T
Enterprise Value	178.11T

Important Dates

The next confirmed earnings date is Wednesday, June 3, 2026.

Earnings Date	Jun 3, 2026
Ex-Dividend Date	Mar 27, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.83%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	86.85%
Float	1.28B

Valuation Ratios

The trailing PE ratio is 22.76 and the forward PE ratio is 14.17.

PE Ratio	22.76
Forward PE	14.17
PS Ratio	2.96
PB Ratio	2.13
P/TBV Ratio	n/a
P/FCF Ratio	19.40
P/OCF Ratio	14.41
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.96, with an EV/FCF ratio of 23.00.

EV / Earnings	26.98
EV / Sales	3.56
EV / EBITDA	12.96
EV / EBIT	19.04
EV / FCF	23.00

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.57.

Current Ratio	2.54
Quick Ratio	1.55
Debt / Equity	0.57
Debt / EBITDA	2.88
Debt / FCF	5.19
Interest Coverage	9.30

Financial Efficiency

Return on equity (ROE) is 9.39% and return on invested capital (ROIC) is 7.98%.

Return on Equity (ROE)	9.39%
Return on Assets (ROA)	4.57%
Return on Invested Capital (ROIC)	7.98%
Return on Capital Employed (ROCE)	8.09%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	534.58M
Profits Per Employee	69.50M
Employee Count	95,000
Asset Turnover	0.39
Inventory Turnover	2.07

Taxes

In the past 12 months, Medtronic has paid 1.32 trillion in taxes.

Income Tax	1.32T
Effective Tax Rate	16.59%

Stock Price Statistics

The stock price has increased by +21.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+21.86%
50-Day Moving Average	33,092.40
200-Day Moving Average	34,324.98
Relative Strength Index (RSI)	38.29
Average Volume (20 Days)	579

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.80

Income Statement

In the last 12 months, Medtronic had revenue of ARS 50.78 trillion and earned 6.60 trillion in profits. Earnings per share was 5,123.47.

Revenue	50.78T
Gross Profit	33.09T
Operating Income	9.49T
Pretax Income	7.96T
Net Income	6.60T
EBITDA	13.51T
EBIT	9.49T
Earnings Per Share (EPS)	5,123.47

Balance Sheet

The company has 12.00 trillion in cash and 40.18 trillion in debt, giving a net cash position of -27,971.37 billion.

Cash & Cash Equivalents	12.00T
Total Debt	40.18T
Net Cash	-27,971.37B
Net Cash Per Share	n/a
Equity (Book Value)	70.41T
Book Value Per Share	54,627.68
Working Capital	20.86T

Cash Flow

In the last 12 months, operating cash flow was 10.43 trillion and capital expenditures -2,683.50 billion, giving a free cash flow of 7.74 trillion.

Operating Cash Flow	10.43T
Capital Expenditures	-2,683.50B
Depreciation & Amortization	3.98T
Net Borrowing	-1,431.87B
Free Cash Flow	7.74T
FCF Per Share	n/a

Margins

Gross margin is 65.16%, with operating and profit margins of 18.68% and 13.00%.

Gross Margin	65.16%
Operating Margin	18.68%
Pretax Margin	15.67%
Profit Margin	13.00%
EBITDA Margin	26.60%
EBIT Margin	18.68%
FCF Margin	15.25%

Dividends & Yields

This stock pays an annual dividend of 642.36, which amounts to a dividend yield of 2.09%.

Dividend Per Share	642.36
Dividend Yield	2.09%
Dividend Growth (YoY)	36.23%
Years of Dividend Growth	16
Payout Ratio	12.54%
Buyback Yield	0.83%
Shareholder Yield	2.87%
Earnings Yield	4.39%
FCF Yield	5.15%

Dividend Details

Stock Splits

The last stock split was on October 22, 2020. It was a forward split with a ratio of 2.

Last Split Date	Oct 22, 2020
Split Type	Forward
Split Ratio	2

Scores

Medtronic has an Altman Z-Score of 2.98 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.98
Piotroski F-Score	6